outbrain
Close  
says he will sign it 'twice over'

Duterte throws support to EO on drug price cap

/ 02:58 PM January 13, 2020

MANILA, Philippines — President Rodrigo Duterte has vowed to support the Department of Health’s (DOH) efforts to lower prices of selected high-cost medicines under the Maximum Drug Retail Price (MDRP) scheme.

The health department last month said the proposed Executive Order on MDRP is being discussed and refined with the help of the Department of Finance, Department of Trade and Industry, National Economic Development Authority, and the Philippine Competition Commission to ensure that the final price reduction initiative of the Duterte administration will have health and economic balance.

ADVERTISEMENT

Duterte, in an exclusive interview with ABS-CBN aired Monday, said he would even sign the proposed EO “twice over” as it is good of the Filipino people.

“I will sign it. I will sign it. That’s good for the Filipino, reduced prices or maintaining a price. I will even sign the document twice over,” Duterte said.

FEATURED STORIES

The DOH has proposed to regulate prices of over 120 drugs used to treat several diseases and health conditions such as hypertension, diabetes, cardiovascular disease, chronic lung diseases, neonatal diseases or those affecting newborn babies, and major cancers.

The President, however, claimed that the draft of the EO has yet to reach his table.

“Wala pa, maybe they are reviewing it. Kapag nasa table ko, sa gabi, binabasa ko. I have not come across any, I heard of it but hard facts are not yet there. But in principle, I will even sign it twice over,” he said.

Read Next
EDITORS' PICK
MOST READ
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: cheaper medicine, DoH, Economy, Health, Malacañang, maximum drug retail price, MDRP
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2020 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.